Gilad Doitsh

Principal Scientist @Vaxart, Inc.

San Francisco, CA, US
EMAILS
g••••••@vaxart.com
MOBILE NUMBERS
+14•••••••27

Signup · Get unlimited contacts

WORK HISTORY

May 2022 — Present

Principal Scientist @Vaxart, Inc.

View department →

South San Francisco, CA, US

Development of oral-based mucosal vaccines targeting viral infections and cancer (HPV-cervical cancer). • Improving vector stability (DNA/RNA) and optimization of antigen expression.• Exploring novel mRNA delivery technologies (both viral and non-viral vectors).• Evaluating clinical and pre-clinical samples to determine vaccine potency and immune responses. • Assessing serum neutralization capacity (IC50) against viral infection using a cell-based neutralization assay with a modular luciferase reporter pseudovirus.

EDUCATION

1999 — 2004

Weizmann Institute of Science

Doctor of Philosophy (Ph.D.), Molecular Genetics, Molecular Virology

1997 — 1999

Weizmann Institute of Science

Master of Science (M.Sc.), Molecular Genetics

1993 — 1996

Tel Aviv University

Bachelor of Science (B.S.), Life Sciences

SKILLS

MicrobiologyCaspase-1ImmunologyMolecular GeneticsDnaProtein ChemistryMicrobial PathogenesisRt-PcrQpcrCell BiologyVirologyImmunoprecipitationInflammasomeMolecular BiologyInnate ImmunityKrav MagaReal-Time Polymerase Chain Reaction (Qpcr)ShrnaVirus CultureCell-to-Cell Transmission of VirusesDrug DiscoveryScienceBiochemistryHbvVirological SynapseHuman Lymphoid Aggregate Cultures (Hlacs)Lymphoid TissuesFlow CytometryWestern BlottingInflammationRnaConfocal MicroscopyHiv

ABOUT GILAD DOITSH

Principal Scientist, Oral-Based Vaccines Against Chronic Infections and Cancer.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.